Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5+
SponsorJose Ivan Rodriguez de Molina Serrano
About this trial
This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.
Eligibility criteria
Qualifiers
Patients aged ≥5 years
Laboratory-confirmed dengue infection (NS1, IgM, or PCR)
First contact at emergency or outpatient services
Informed consent signed by the patient or legal guardian
Disqualifiers
Co-infection with other arboviruses or COVID-19
Pre-existing hematologic or oncologic disease
Refusal to sign informed consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 1 trial groupSponsors and collaborators
Jose Ivan Rodriguez de Molina Serrano
Lead sponsor
Clinica Mexico
Sponsor institution
Source ClinicalTrials.gov